'hypertension management through combination therapy'

Zilarta-CT 40 Tablet is a combination medicine used in the treatment of hypertension (high blood pressure). It works by relaxing the blood vessels and making the heart more efficient at pumping blood throughout the body. It also removes extra water and certain electrolytes from the body.

Zilarbi CT 40mg/12.5mg Tablet is a combination medicine used in the treatment of hypertension (high blood pressure). It works by relaxing the blood vessels and making the heart more efficient at pumping blood throughout the body. It also removes extra water and certain electrolytes from the body.

Dapasmart M 10/1000 is a prescription medication used to manage type 2 diabetes. It combines two active ingredients: dapagliflozin (10mg) and metformin (1000mg). Dapagliflozin, an SGLT2 inhibitor, helps the kidneys remove excess sugar through urine, while metformin, a biguanide, reduces glucose production in the liver. This combination helps lower blood sugar levels in people with type 2 diabetes.

Angiotensin-H tablets are a combination of two medicines used to treat high blood pressure (hypertension)

CAPCNAMO 500 Tablet is used in the treatment of cancer of breast, colon, and rectum. It may be also used to treat other conditions, as determined by the doctor. It is used alone or in combination with some other medicine as a part of chemotherapy.

Fludacel 50mg Injection is used in the treatment of blood cancer called chronic lymphocytic leukemia (CLL). It may be used to treat other conditions, as determined by the doctor. It is sometimes used with certain other medicines as part of combination chemotherapy.

TELMAVAC AM 80/5MG TABLET is used in the management of hypertension. It is preferably used when treatment with single BP medicines does not provide adequate control in blood pressure.

S-One Trio Capsule is a combination medicine used in the treatment of stomach cancer. It can be used alone or in combination with some medicines as part of combination chemotherapy. It works by interfering with the growth of cancer cells, which are eventually destroyed.

Peginterferon alfa-2a is a form of recombinant interferon used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients 3